MedPath

Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO
Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Associated Conditions
Agitation, Alcohol Withdrawal Syndrome
Associated Therapies
-

Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor Resection

Not Applicable
Completed
Conditions
Dexmedetomidine
Perioperative
Electrolyte
Interventions
Drug: Normal saline
Drug: Dexmedetomidine
First Posted Date
2021-02-25
Last Posted Date
2021-11-30
Lead Sponsor
Yangzhou University
Target Recruit Count
140
Registration Number
NCT04771637
Locations
🇨🇳

the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China

Intravenous Dexamethasone and Dexmedetomidine on the Analgesic Efficacy of Erector Spinae Plane Block

Not Applicable
Completed
Conditions
Dexamethasone
Dexmedetomidine
Nerve Block
Interventions
Drug: Dexamethasone and dexmedetomidine
Drug: Dexmedetomidine
Other: Ultrasound-guided lumbar erector spinae plane block
Other: PCIA
First Posted Date
2021-02-23
Last Posted Date
2022-03-29
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
120
Registration Number
NCT04767256
Locations
🇨🇳

Union Hospital, Wuhan, Hubei, China

The Effect of Dexmedetomidine on Kidney Function in EVAR

Not Applicable
Conditions
Acute Kidney Injury
Dexmedetomidine
Endovascular Aortic Repair
Interventions
First Posted Date
2021-02-23
Last Posted Date
2021-04-28
Lead Sponsor
University of Thessaly
Target Recruit Count
200
Registration Number
NCT04766047
Locations
🇬🇷

Univeristy of Thessaly, Larissa, Thessaly, Greece

Clonidine vs. Dexmedetomidine in Agitated Delirium in Intensive Care Patients

Phase 4
Conditions
Critical Illness
Delirium
Interventions
First Posted Date
2021-02-17
Last Posted Date
2021-02-17
Lead Sponsor
Erasme University Hospital
Target Recruit Count
50
Registration Number
NCT04758936
Locations
🇧🇪

Clinique Saint-Pierre, Ottignies, Belgium

🇧🇪

CUB Erasme Hospital ULB, Bruxelles, Belgium

🇧🇪

Civil hospital Marie Curie, Charleroi, Belgium

Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

Phase 4
Conditions
Coronary Artery Disease
Postoperative Shivering
Interventions
First Posted Date
2021-02-03
Last Posted Date
2022-01-10
Lead Sponsor
Qianfoshan Hospital
Target Recruit Count
180
Registration Number
NCT04735965
Locations
🇨🇳

China, Shandong Qianfoshan Hospital, Jinan, Shandong, China

Evaluation of Remifentanil and Dexmedetomidine in Patients With Noninvasive Mechanical Ventilation Intolerance

Not Applicable
Conditions
NIV Intolerance
Interventions
First Posted Date
2021-02-02
Last Posted Date
2021-03-16
Lead Sponsor
Shanghai Zhongshan Hospital
Target Recruit Count
178
Registration Number
NCT04734418
Locations
🇨🇳

Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

Phase 4
Recruiting
Conditions
Shivering
Dose Finding Study
Interventions
First Posted Date
2021-01-29
Last Posted Date
2023-09-29
Lead Sponsor
Mayo Clinic
Target Recruit Count
40
Registration Number
NCT04730609
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Cognitive Dysfunction After Cataract Surgery

Not Applicable
Completed
Conditions
POCD - Postoperative Cognitive Dysfunction
Interventions
First Posted Date
2021-01-29
Last Posted Date
2021-04-20
Lead Sponsor
Tanta University
Target Recruit Count
90
Registration Number
NCT04730596
Locations
🇪🇬

Faculty of Medicine, Tanta, Algharbia Governate, Egypt

Intranasal Remimazolam for Premedication in Pediatric Patient

Phase 4
Completed
Conditions
Sedative; Anxiety Disorder
Interventions
Other: Distilled water for injection
Drug: Remimazolam
Drug: Dexmedetomidine
First Posted Date
2021-01-22
Last Posted Date
2023-09-08
Lead Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
90
Registration Number
NCT04720963
Locations
🇨🇳

The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Effects of Dexmedetomidine vs Propofol in Patients With Intra-abdominal Sepsis

Phase 4
Completed
Conditions
Septic Peritonitis
Interventions
First Posted Date
2021-01-22
Last Posted Date
2021-04-27
Lead Sponsor
Assiut University
Target Recruit Count
60
Registration Number
NCT04718714
Locations
🇪🇬

Faculty of Medicine, Assiut University, Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath